2026-09-08T15:04:04-05:00 2025-12-31 521446779 JOHNSON LAMBERT LLP 4242 SIX FORKS ROAD SUITE 1500 RALEIGH NC 27609 990 2025-01-01 030466352 THE GOG FOUNDATION INC GOGF 4107217126 3168 BRAVERTON ST 280 EDGEWATER MD 21037 THOMAS WALSH CHIEF FINANCIAL OFFICER 4107217126 2026-09-08 1 J CALVIN MARKS P01226973 9197196400 2025 THOMAS HERZOG MD 3168 BRAVERTON ST 280 EDGEWATER MD 21037 123118078 0 X WWW.GOG.ORG X 2002 DC THE GOG FOUNDATION'S PRIMARY EXEMPT PURPOSE IS TO PROMOTE EXCELLENCE IN THE QUALITY AND INTEGRITY OF CLINICAL AND BASIC SCIENTIFIC RESEARCH IN THE FIELD OF GYNECOLOGIC MALIGNANCIES. 17 6 76 6 -969 0 3519415 3858127 60324530 82361494 4516331 5964248 116810 240811 68477086 92424680 214200 199175 0 0 10610145 11646407 0 0 84418 54249265 70376605 65073610 82222187 3403476 10202493 145468069 171347628 47814920 57925938 97653149 113421690 X THE GOG FOUNDATION, INC. (GOG FOUNDATION) IS A NONPROFIT ORGANIZATION WITH THE PURPOSE OF PROMOTING EXCELLENCE IN THE QUALITY AND INTEGRITY OF CLINICAL AND BASIC SCIENTIFIC RESEARCH IN THE FIELD OF GYNECOLOGIC MALIGNANCIES, INCLUDING CANCERS THAT ARISE FROM THE OVARIES, UTERUS, CERVIX, VAGINA, AND VULVA. OUR INSTITUTIONS AND INVESTIGATORS ARE ESSENTIAL CONTRIBUTORS TO ADVANCEMENTS IN TREATMENT REGIMENS, SURGICAL PROCEDURES, QUALITY OF LIFE ANALYSES, AND PREVENTION KNOWLEDGE. THE RESULTS OF GOG FOUNDATION CLINICAL TRIALS HAVE INFLUENCED THE STANDARD OF CARE FOR NUMEROUS MALIGNANT GYNECOLOGIC NEOPLASMS. THE MISSION OF THE GOG FOUNDATION IS TO CONDUCT CLINICAL AND TRANSLATIONAL RESEARCH THAT POSITIVELY IMPACTS WOMEN THROUGH THE PREVENTION AND TREATMENT OF GYNECOLOGIC MALIGNANCIES. THE VISION OF THE GOG FOUNDATION IS TO BE THE PREMIER COLLABORATIVE NETWORK FOR TRANSFORMATIVE RESEARCH IN GYNECOLOGIC MALIGNANCIES. 0 0 81954722 199175 82361494 THE FOUNDATION IS COMMITTED TO MAINTAINING THE HIGHEST STANDARDS IN CLINICAL TRIALS DEVELOPMENT, EXECUTION, ANALYSIS AND DISTRIBUTION OF RESULTS. CONTINUOUS EVALUATION OF OUR PROCESSES IS UTILIZED IN ORDER TO CONSTANTLY IMPROVE THE QUALITY OF PATIENT CARE. IN 2025 THE GOG FOUNDATION, INC. CONDUCTED CLINICAL TRIALS THROUGH OUR 300 PLUS INSTITUTIONS. THESE EXPENSES INCLUDED PROTOCOL DEVELOPMENT, REGULATORY AFFAIRS, MEETINGS TO REVIEW TRIAL DATA, TRIAL DEVELOPMENT THROUGH COMMITTEE FUNCTIONS AND OTHER INDIRECT RELATED EXPENSES. 81954722 1 1 0 0 0 0 0 0 0 0 0 1 0 0 1 1 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 1 87 0 1 76 1 0 0 0 0 0 0 0 0 0 0 0 0 X 17 6 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 CA MD X THOMAS WALSH CFO 4107217126 3168 BRAVERTON ST NO 280 EDGEWATER MD 21037 X MARY SHARP CFO 35.00 X 322779 0 61993 LAURA L REESE ED, OPERATIONS 35.00 X 301342 0 59538 MICHAEL S POWERS GENERAL COUNSEL 35.00 X 307384 0 48203 JENNIFER T KIEN ED, COMMS, PHILANTHROPY & INDUSTRY REL 35.00 X 253851 0 77749 KATHLEEN E CAMPBELL-SIMMS ED, PARTNERS, CLINICAL TRIALS MGMT 35.00 X 200635 0 69874 NOLA R BENCZE COMPLIANCE ATTORNEY 35.00 X 206501 0 46001 NICOLE M LAMACK SR DIR GRANTS, ACCTING, SITE CONTRACTING 35.00 X 203959 0 48469 CASI A MORALES CLINICAL TRIALS CONTRACTS ATTORNEY 35.00 X 168124 0 64666 HEATHER LANKES DIRECTOR, TRANSLATIONAL RESEARCH 35.00 X 174179 0 56178 WENDY WELLS DIRECTOR, FINANCE 35.00 X 173128 0 55972 JOSH J KILLION SR DIRECTOR, IT 35.00 X 179371 0 41162 JENNIFER KLEIN CLINICAL TRIALS MANAGER 35.00 X 179579 0 27012 THOMAS WALSH CFO (FROM SEP '25) 35.00 X 75057 0 19140 THOMAS J HERZOG MD PRESIDENT 20.00 X X 50000 0 0 LARRY J COPELAND MD IMMEDIATE PAST PRESIDENT 20.00 X X 50000 0 0 ROBERT S MANNEL MD SR. VICE PRESIDENT 13.00 X X 33000 0 0 CAROL AGHAJANIAN MD VICE PRESIDENT 1.00 X X 0 0 0 ROBERT L COLEMAN MD VICE PRESIDENT 1.00 X X 0 0 0 BRADLEY J MONK MD VICE PRESIDENT 1.00 X X 0 0 0 KATHLEEN N MOORE MD TREASURER 1.00 X X 0 0 0 DAVID G MUTCH MD SECRETARY 1.00 X X 0 0 0 PAUL A DISILVESTRO MD VICE PRESIDENT 1.00 X X 0 0 0 ANGELES ALVAREZ SECORD MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 JYOTI MAYADEV MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 TASHANNA MYERS MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 ALEXANDER B OLAWAIYE MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 DAVID O'MALLEY MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 MATTHEW POWELL MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 LESLIE M RANDALL MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 BRIAN SLOMOVITZ MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 2878889 0 675957 32 0 1 0 SARAH CANNON RESEARCH INSTITUTE LLC 1100 DR MARTIN L KING JR BLVD STE 8 NASHVILLE TN 37203 CLINICAL SERVICES 3361489 US ONCOLOGY RESEARCH LLC 10101 WOODLOCH FOREST DR THE WOODLANDS TX 77380 CLINICAL SERVICES 3080472 OHIO STATE RESEARCH FOUNDATION 1960 KENNY RD COLUMBUS OH 43210 CLINICAL SERVICES 1864822 MEMORIAL SLOAN-KETTERING CANCER CENTER 1275 YORK AVE NEW YORK NY 10065 CLINICAL SERVICES 1550246 WCG IRB LLC 5000 CENTREGREEN WAY STE 200 CARY NC 27513 CLINICAL SERVICES 1271839 131 2524549 1333578 3858127 INDUSTRY REVENUE 900099 82250752 82250752 REGISTRATION FEES 900099 110742 110742 82361494 4872995 -969 4873964 92834 0 92834 92834 92834 31784651 30693398 1091253 1091253 1091253 MANAGED SERVICES 541900 80438 80438 NRG ONCOLOGY 900099 65564 65564 1975 1975 147977 92424680 82361494 -969 6206028 199175 199175 2403505 1519529 869109 14867 120099 73779 45345 975 6406521 3998542 2372856 35123 940502 628732 304565 7205 1172129 645025 506572 20532 603651 386961 213203 3487 193860 99560 94300 71519 71519 247419 247419 2542741 2017579 524178 984 1188 1188 203431 52105 150922 404 257227 2974 253774 479 481107 340400 140707 781585 663411 118392 -218 2582758 2533956 48787 15 475216 475216 PURCHASE SERVICE AGREEM 61317668 61317668 CONSORTIUMS 717043 717043 HONORARIA 210030 210030 OVERHEAD ALLOCATION 0 6476794 -6476794 293813 71459 221789 565 82222187 81954722 183047 84418 2481 28475080 32358091 646100 669836 9295373 21670752 5676 332212 88508047 98208581 15949408 15998245 810521 764477 1775383 1345434 145468069 171347628 1099988 10140746 44568330 46156795 2146602 1628397 47814920 57925938 X 97653149 113421690 97653149 113421690 145468069 171347628 X 10202493 5441048 125000 X 0 1 X 1 1 1 X 2532775 2549203 3098708 3519415 3858127 15558228 2532775 2549203 3098708 3519415 3858127 15558228 15558228 2322219 2238523 3962455 4776326 4966798 18266321 17268 42782 60050 139537 95112 179336 65205 147977 627167 34511766 339547101 0.45080 0.48450 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 ALTERNATIVE INVESTMENTS 15998245 C 15998245 LEASE LIABILITIES - OPERATING LEASES 1628397 1628397 X 97618309 5441048 5441048 92177261 247419 247419 92424680 81849768 -125000 -125000 81974768 247419 247419 82222187 PART X, LINE 2: MANAGEMENT HAS CONCLUDED THAT GOG FOUNDATION HAS PROPERLY MAINTAINED ITS EXEMPT STATUS, AND THERE ARE NO UNCERTAIN TAX POSITIONS AS OF DECEMBER 31, 2025 OR 2024. PART XII, LINE 2D - OTHER ADJUSTMENTS: RETURN OF GRANT FROM PRIOR PERIOD -125,000. CENTRAL AMERICA AND THE CARIBBEAN 0 0 INVESTMENTS 1858000 NORTH AMERICA 0 9 CLINICAL SERVICES RESEARCH SERVICES 1011000 SOUTH AMERICA 0 1 CLINICAL SERVICES RESEARCH SERVICES 920000 EUROPE 0 4 CLINICAL SERVICES RESEARCH AND OTHER PROFESSIONAL SERVICES 676000 EAST ASIA 0 1 CLINICAL SERVICES RESEARCH SERVICES 54000 SUB-SAHARAN AFRICA 0 1 CLINICAL SERVICES OTHER PROFESSIONAL SERVICES 1000 0 16 0 0 0 16 4520000 0 4520000 1 0 1 1 1 0 1 DUKE UNIVERSITY 2200 W MAIN ST STE 300 DURHAM NC 27705 560532129 501(C)(3) 131250 0 GENERAL SUPPORT AMERICAN ASSOCIATION OF OBSTETRICIANS & GYN FOUNDATION 2331 ROCK SPRING RD FOREST HILL MD 21050 386042799 501(C)(3) 60425 0 GENERAL SUPPORT FOUNDATION FOR WOMEN'S CANCER 620 N LA SALLE DR CHICAGO IL 60654 237067756 501(C)(3) 7500 0 GENERAL SUPPORT 3 0 PART I, LINE 2: THE GOG FOUNDATION SELECTS ORGANIZATIONS FOR GRANTS THAT FURTHER THE EXEMPT PURPOSE OF THE GOG FOUNDATION. THE RECIPIENTS OF THESE GRANTS ARE EXEMPT ORGANIZATIONS WITH MISSIONS CONGRUOUS WITH THOSE OF THE GOG FOUNDATION. X X 0 0 0 0 0 0 0 0 0 MARY SHARP CFO 317526 0 5000 0 253 0 48890 0 13103 0 384772 0 0 0 LAURA L REESE ED, OPERATIONS 282089 0 19000 0 253 0 45675 0 13863 0 360880 0 0 0 MICHAEL S POWERS GENERAL COUNSEL 302384 0 5000 0 0 0 46333 0 1870 0 355587 0 0 0 JENNIFER T KIEN ED, COMMS, PHILANTHROPY & INDUSTRY R 248408 0 5000 0 443 0 39024 0 38725 0 331600 0 0 0 KATHLEEN E CAMPBELL-SIMMS ED, PARTNERS, CLINICAL TRIALS MGMT 195211 0 5000 0 424 0 31039 0 38835 0 270509 0 0 0 NOLA R BENCZE COMPLIANCE ATTORNEY 202168 0 4080 0 253 0 31475 0 14526 0 252502 0 0 0 NICOLE M LAMACK SR DIR GRANTS, ACCTING, SITE CONTRAC 193794 0 9919 0 246 0 31265 0 17204 0 252428 0 0 0 CASI A MORALES CLINICAL TRIALS CONTRACTS ATTORNEY 163553 0 4197 0 374 0 26091 0 38575 0 232790 0 0 0 HEATHER LANKES DIRECTOR, TRANSLATIONAL RESEARCH 169617 0 4326 0 236 0 26868 0 29310 0 230357 0 0 0 WENDY WELLS DIRECTOR, FINANCE 168380 0 4306 0 442 0 26776 0 29196 0 229100 0 0 0 JOSH J KILLION SR DIRECTOR, IT 174849 0 4409 0 113 0 27358 0 13804 0 220533 0 0 0 JENNIFER KLEIN CLINICAL TRIALS MANAGER 179579 0 0 0 0 0 27012 0 0 0 206591 0 0 0 THOMAS J HERZOG MD PRESIDENT 424403 CONSULTING SERVICES 0 BRADLEY J MONK MD VICE PRESIDENT 303473 CONSULTING, PROVIDED BY BUSINESS OWNED BY OFFICER 0 LARRY J COPELAND MD IMMEDIATE PAST PRESIDENT 208000 CONSULTING SERVICES 0 DAVID O'MALLEY MD DIRECTOR-AT-LARGE 140530 CONSULTING SERVICES 0 BRIAN SLOMOVITZ MD DIRECTOR-AT-LARGE 130132 CONSULTING SERVICES 0 KATHLEEN N MOORE MD TREASURER 127700 CONSULTING SERVICES, PAID TO EMPLOYER 0 ROBERT L COLEMAN MD VICE PRESIDENT 127138 CONSULTING SERVICES 0 NICOLE COPELAND FAMILY MEMBER OF OFFICER 120098 EMPLOYEE WAGES 0 LESLIE M RANDALL MD DIRECTOR-AT-LARGE 76500 CONSULTING SERVICES 0 ROBERT S MANNEL MD SR. VICE PRESIDENT 67000 CONSULTING SERVICES, PAID TO EMPLOYER 0 ANGELES ALVAREZ SECORD MD DIRECTOR-AT-LARGE 24075 CONSULTING SERVICES 0 ALEXANDER B OLAWAIYE MD DIRECTOR-AT-LARGE 11575 CONSULTING SERVICES 0 FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS REVIEWED BY THE CFO BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST DISCLOSURE FORMS ARE REVIEWED ANNUALLY BY THE FOUNDATION CHAIR, AND ON AN INTERIM BASIS. THE FOUNDATION CHAIR REVIEWS ANNUAL FORMS NO LATER THAN NOVEMBER 1 OF EACH YEAR, AND INTERIM FORMS WITHIN 30 DAYS. THE CONFLICT IS MANAGED, REDUCED, OR ELIMINATED, AT LEAST ON AN INTERIM BASIS, WITHIN 60 DAYS OF ITS IDENTIFICATION. FORM 990, PART VI, SECTION B, LINE 15 OFFICER AND KEY EMPLOYEE SALARY IS APPROVED BY THE PRESIDENT AND TREASURER ANNUALLY, IN CONSULTATION WITH A COMPENSATION SURVEY WHICH IS OBTAINED PERIODICALLY. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, POLICIES, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE AT RECEPTIONIST'S DESK. FORM 990, PART VII, SECTION A: DR. MANNEL'S EMPLOYER, THE UNIVERSITY OF OKLAHOMA, WAS COMPENSATED $33,000 FOR DR. MANNEL'S SERVICES TO THE BOARD. FORM 990, PART XI, LINE 9: RETURN OF GRANT FROM PRIOR PERIOD 125,000.